Hikmat A. Al-Ahmadie, MD

Memorial Sloan Kettering Cancer Center

Dr. Al-Ahmadie is an Associate Attending Pathologist at Memorial Sloan Kettering Cancer Center. His clinical focus is on the diagnosis of tumors of the GU system and his academic and research focus is the pathology and molecular biology of urothelial neoplasia. Of particular research interest to him is the investigation of the molecular basis for the development and progression of urothelial carcinoma and the mechanisms responsible for the pathologic and clinical heterogeneity commonly identified in bladder cancer. He is an NIH-funded investigator and serves as the Director of the Biospecimen Core for the MSKCC SPORE in Bladder Cancer. He served as the lead pathologist for the Bladder Cancer Analysis Working Group of The Cancer Genome Atlas.

Kimberly Allison, MD, FCAP

Stanford Health Care

Dr. Allison is the Director of Breast Pathology and Professor of Pathology at Stanford University School of Medicine. She earned a BA from Princeton University in Molecular Biology, an MD from New York Medical College, and certification in anatomical and clinical pathology from the American Board of Pathology. Her residency and fellowship training were completed at the University of Washington Medical Center. She has a special interest in development of high-quality diagnostic standards and is active in setting practice guidelines and patient communication. She is on the editorial board for the 5th edition of the WHO Classification of Tumours of the Breast, is co-chair of the ASCO/CAP ER/PR Testing in Breast Cancer committee, was on the steering committee for the 2018 ASCO/CAP HER2 Testing Guidelines Update, and serves on the NCCN Breast Cancer Treatment Guidelines committee. She is actively involved in resident/fellow training as Vice Chair of Education, Director of the Stanford Breast Pathology Fellowship and Residency Director for the Department of Pathology. Dr. Allison has also experienced “the other side of the microscope” as a breast cancer patient; an experience which inspired her to publish her memoir, “Red Sunshine,” and advocate for public awareness of pathology’s role in cancer care.

Mahul B. Amin, MD, FCAP

University of Tennessee Health Science Center

Dr. Amin is the Clinical Professor of Pathology and Laboratory Medicine at the University of Tennessee Health Science Center, and Adjunct Clinical Professor of Urology at the USC Keck School of Medicine. He is the Vice President and Divisional Medical Director, West Division at Labcorp, where he leads the development and execution of the medical and science strategy for the entire West Division to assure delivery of the highest quality of Lab solutions and diagnostics to Labcorp physicians and patients. At an enterprise level at Labcorp, he provides senior medical leadership perspective to the Oncology, Digital Pathology and Artificial Intelligence programs. Dr. Amin has 22 years leadership experience in academic pathology departments and has served as Director of Surgical Pathology at Emory University (1998-2006), Professor and Chairman of Pathology and Lab. Medicine at Cedars Sinai (2006-2015) and Professor and Chair of Pathology and Lab. Medicine at the University of Tennessee Health Science Center (2017-2020). From 2001 to 2009, as Vice Chair and then as Chair of the Cancer Committee of the College of American Pathologists (CAP), Dr. Amin led the cause for standardized pathologic reporting of all cancer in the United States and the committees' work resulted in one of the important standards of the American College of Surgeons, Commission on Cancer center accreditation program in the United States and the CAP's laboratory accreditation program. In 2013, he was appointed as Editor-in-Chief of the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual where he coordinated the activities of over 425 contributors to outline the next edition of cancer staging. Dr. Amin’s scientific interests are in the discovery and validation of biomarkers in urologic malignancies for clinical personalized medicine and in Artificial Intelligence applications in Pathology. He has authored 385 publications and 73 book chapters. He has also co-authored 13 books (two in their second and third editions) including two-Armed Forces Institute of Pathology (AFIP) fascicles, two major texts in urologic pathology and a monograph on Gleason grading of prostate cancer. Dr. Amin is a much sought of as a speaker and has given over 400 pathology grand rounds, lectures, and workshops. He has extensively spoken around the world and lectured in 31 countries and 75 cities outside of the US; often on multiple occasions. Dr. Amin co-authored the 2002 World Health Organization (WHO) classification systems for urothelial tumors and renal neoplasms (authored 7 chapters); and the 2016 WHO classification systems for tumors of the prostate, bladder, kidney, penis, and testis (authored 21 chapters). He has just been appointed on the WHO Blue Books Editorial Board for the upcoming Urinary and Male Genital Tumours volume (WHO 2021). He has made many significant and pioneering contributions including the first major descriptions of entities in genitourinary pathology including lymphoepithelioma-like carcinoma of the bladder, micropapillary carcinoma of the bladder, acquired cystic disease associated renal cell carcinoma, clear cell-papillary renal cell carcinoma, thyroid-like carcinoma of the kidney, tubulocystic carcinoma of the kidney, intratubular large cell hyalinizing Sertoli cell neoplasia of the testis (a distinctive condition of the Peutz-Jeghers syndrome), and low-grade glandular tumors of the urachus. He has recently authored some of the first major series and descriptions on Succinate dehydrogenase - deficient renal cell carcinoma and Fumarate hydratase- deficient renal cell carcinoma, including description of a new subtype of renal cell carcinoma - low grade oncocytic Fumarate Hydratase deficient renal cell carcinoma. Dr. Amin is also the recipient of highly prestigious awards through the College of American Pathologists including the 2010 CAP Foundation Lansky Award and the 2010 CAP Distinguished Service Award.

Christina A. Arnold, MD, FCAP

University of Colorado

Dr. Christina Arnold is a GI Pathologist at the University of Colorado, is a Master-level, certified professional coach, and is the voice behind the Your Path in Focus podcast. She helps physicians feel better and ditch burnout and boredom forever. The secret is to work less without guilt. She specializes in imposter syndrome, burnout, negotiations, difficult people, perfectionism, approval addiction, and getting the best sleep of your LIFE. She is a series editor of an Atlas-based textbook series that currently includes six textbooks, and she has authored over 100 publications and delivered more than 200 invited lectures on trending topics in GI pathology, Social Media, and Professional Coaching. Dr. Arnold served on the Curriculum Education Committee for the College of American Pathologists (CAP), was an Editor for the American Journal of Surgical Pathology and Archives of Pathology & Laboratory Medicine, and is the incoming president for the Rodger C. Haggitt Gastrointestinal Pathology Society. She has been featured on The Pathologist’s Powerlist, was named in the Top 40UnderForty by the American Society for Clinical Pathology, and has received a number of teaching, leadership, and service awards.

Jacqueline E. Birkness-Gartman, MD

John Hopkins Medicine

Jacqueline (Jackie) Birkness-Gartman, MD, is an assistant professor of pathology at the Johns Hopkins University School of Medicine, where she previously completed her residency and fellowship in gastrointestinal and liver pathology. She is board certified in anatomic and clinical pathology. Her academic interests include upper gastrointestinal tract pathology, appendiceal pathology, and graduate medical education.

Phyu P. Aung, MD, PhD, FCAP

MD Anderson Cancer Center

Phyu P. Aung, MD, PhD, FCAP is an Associate Professor in the Department of Pathology (Section of Dermatopathology) at The University of Texas MD Anderson Cancer Center (UT-MDACC). Dr. Aung earned her Medical Degree from the Institute of Medicine of Rangoon (Burma). She received her Ph.D. in Molecular Pathology from Hiroshima University School of Medicine in Japan. Subsequently, she completed a research fellowship at Cleveland Clinic, OH. Dr. Aung then completed her residency in Anatomic Pathology at the National Cancer Institute/NIH, MD, where she served as Chief Resident, and after this, she completed her fellowship in Dermatopathology at Boston Medical Center. Following her training, Dr. Aung joined the faculty at UT-MDACC in 2014. Her work in Cancer biology and cutaneous lesions has resulted in more than 170 original publications in peer reviewed journals, over 10 book chapters and approximately 250 poster/platform presentations at national (USA) and international conferences as well as 15 intra- and extra-mural Grants. Dr. Aung is an active member/ the Executive Committee of multiple Pathology and Dermatopathology Societies, grant reviewers of 5 national and international societies including NIH, and an invited speaker/organizer/moderator in more than 75 national and international universities as well as conferences. Special interests include melanocytic neoplasms, rare cutaneous neoplasms such as Merkel cell carcinoma and molecular advancement of diagnostic Dermatopathology. Dr. Aung is also the Director of the Oncologic Surgical Pathology Fellowship Program with 14 fellows and Site Director of Educational Rotation Program at MD Anderson Cancer Center. She is a very passionate teacher and has mentored over 100 national and international residents, fellows and practicing physicians.

Rania Bakkar, MD, FCAP

Cedars-Sinai Medical Center

Rania Bakkar, MD, is an associate professor of pathology at City of Hope National Cancer Center, CA. She is the women’s cancers section chief at the Department of Pathology . She obtained her Oncologic Surgical Pathology and Cancer Biomarkers in Breast and Gynecologic Cancers Fellowships at MD Anderson Cancer Center, TX. She is board certified in anatomic and clinical pathology and has been practicing pathology, with subspecialty expertise in breast and gynecologic pathology, since 2011. Her publications, including multiple book chapters and research focus on cancer biometrics, molecular pathogenesis and biomarkers as prognostic and predictive tools in breast and gynecologic cancers.

Zubair W. Baloch, MD, PhD, FCAP

Zubair W. Baloch, MD, PhD, FCAP

Dr. Baloch received his medical degree from Liaquat Medical University in Hyderabad, Sind, Pakistan. After receiving his PhD in 1991, he joined the pathology residency at Hahnemann University Hospital. This was followed by fellowships in surgical pathology at Memorial Sloan Kettering Cancer Center, New York and cytopathology at the University of Pennsylvania Medical Center, Philadelphia under the mentorship of Dr. Prabodh K. Gupta (past president ASC). Dr. Baloch began his career as an assistant professor in the Department of Pathology & Laboratory Medicine at UPENN medical center in1997 and is currently a professor of pathology and laboratory medicine there. He has authored more than 200 peer reviewed publications in leading pathology journals on the subject of endocrine and head and neck pathology; and book chapters and monographs. Dr. Baloch has delivered numerous lectures, workshops and short courses both at the national and international meetings including ASC, USCAP, ASCP, CAP, ECC and IAP. Dr. Baloch has coauthored 3 books and has served as co-editor of the most recent “Milan System for Reporting Salivary Gland Cytopathology”. Dr. Baloch has also served as the chair of the terminology and morphologic criteria committee of the 2007 NCI sponsored thyroid FNA initiative which led to the development of “Bethesda Thyroid FNA Classification Scheme”. Dr. Baloch also served on the international panel which recommended the renaming of encapsulated follicular variant of papillary thyroid carcinoma to non-invasive follicular tumor with papillary like nuclear features (NIFTP). Dr. Baloch is Chief editor of Diagnostic Cytopathology and member of the editorial board of Cancer Cytopathology, Cytojournal, Endocrine Pathology and Journal of American Society of Cytopathology.Dr. Baloch has served as the chair of ASCP annual meeting scientific program committee (2014-2018), member of Papanicolaou Society scientific program committee, USCAP education committee, ASC executive board and chair of the scientific program committee, ASCP committee for continuing professional development, American Association of Endocrinologist thyroid nodule guideline task force, American Thyroid Association laboratory test committee and well-differentiated thyroid carcinoma management guidelines committee and currently is one of the editors of the WHO Classification of Tumors of Neuroendocrine Organs. Dr. Baloch has received many awards from University of Pennsylvania, Papanicolaou society of pathology, Philadelphia pathology society, and American Society of the Clinical Pathology.

Guliz A. Barkan, MD, FCAP

Loyola University Medical Center

Güliz A. Barkan, MD, FIAC is a board certified Anatomic Pathologist and Cytopathologist, Professor of Pathology and Urology, and currently the Director of Cytopathology, and the Director of the Cytopathology Fellowship Program at Loyola University Medical Center, Maywood, IL. Dr. Barkan received her medical degree from Marmara University School of Medicine in Istanbul, Turkey in 1995. She completed residency in Anatomic and Clinical Pathology at the University of Michigan, Ann Arbor, Michigan in 2001. She finished a Surgical Pathology fellowship in the same institution in 2002 and a Cytopathology fellowship at the University of Texas, M.D. Anderson Cancer Center, Houston, Texas in 2003. After a brief period in private practice in Turkey, she joined Loyola University Department of Pathology and Laboratory Medicine in February 2006, and has been there since then. Her interests include cytopathology and surgical pathology of the genitourinary tract, and pathology education. She has authored a number of peer-reviewed publications, abstracts, chapters, and given national and international invited talks and workshops mostly in the fields of cytopathology and surgical pathology of the genitourinary system.  Dr. Barkan is also a fellow of the International Academy of Cytology, and has previously served as a member of the American Board of Pathology, Test Development Committee and on the College of American Pathologists Cytopathology committee. Dr. Barkan is the current president of the American Society of Cytopathology.

Olca Basturk, MD

Memorial Sloan Kettering Cancer Center

Olca Basturk, MD, FCAP is a world-renowned pathologist in the field of pancreas and biliary tract pathology. Dr. Basturk earned her MD from the Ege University School of Medicine in Izmir, Turkey. She then successfully completed her anatomic and clinical pathology at New York University, New York, NY and oncologic surgical pathology as well as gastrointestinal pathology fellowships at Memorial Sloan Kettering Cancer Center, New York, NY. Dr. Basturk joined the faculty of Memorial Sloan Kettering Cancer Center and Weill Medical College, Cornell University in 2012. Since then, she has conducted numerous scientific studies on pancreas, gallbladder and biliary cancers and published 150 Pubmed-indexed manuscripts as well as more than 40 book chapters, including multiple chapters in the new WHO Classifications of Tumours of the Digestive System (2019) and Neuroendocrine Tumors (2022). She is on the editorial boards of leading pathology journals, including Modern Pathology and the Archives of Pathology & Laboratory Medicine (section editor for Gastrointestinal Pathology). Dr. Basturk is also a founding member of Pancreatobiliary Pathology Society and served as the Chair of the Society’s Education Committee. She is currently the President of the Society.

Sarah M. Bean, MD, FCAP

Duke University Health System

Dr. Sarah M. Bean is a Professor of Pathology and Vice-Chair of Faculty at Duke University Medical Center. Dr. Bean earned her medical degree at the University of Rochester School of Medicine and Dentistry in Rochester, NY. She completed residency in Anatomic and Clinical Pathology and a fellowship in Cytopathology at the University of Alabama at Birmingham. In 2006, she joined faculty at Duke University. Her clinical activities encompass diagnostic breast and gynecologic surgical pathology, intraoperative consultations, and cytopathology. Dr. Bean has developed expertise in medical education, including feedback, teaching, mentoring, and leadership. She currently serves as program director for the Cytopathology fellowship and for the Surgical Pathology fellowship. Previously, she was Chair of the inaugural Clinical Competency Committee (CCC) for the Pathology Residency program. She has served on numerous departmental, institutional, and national education-related committees. Most notably, she served as Chair of the Curriculum Committee in the College of American Pathologists (CAP). She was also a member of the CAP Council on Education. Currently, she is a member of the CAP Publications Committee, a Pathology Education Section Editor for Archives of Pathology and Laboratory Medicine, and a member of the Editorial Board for CAP Today. Dr. Bean also is faculty for the Association of American Medical Colleges (AAMC) Leadership Education and Development (LEAD) program, a leadership program for developing medical educators. Dr. Bean has been recognized for her excellence in teaching and education. She received the Bernard F. Fetter Teaching Award in Pathology in 2009 and again in 2014. She received the AAMC Southern Group on Educational Affairs (SGEA) Medical Education Scholarship Award for Outstanding Presentation twice. She was one of seven Duke Academy for Health Professions Education and Academic Development (AHEAD) members recognized in the inaugural class of Fellow members. She was also recognized by the American Society of Clinical Pathology (ASCP) as a 40 Under Forty honoree in 2015. Mre recently, she received the CAP Outstanding Educator Award in 2020.

Andrew Bellizzi, MD, FCAP

University of Iowa Hospitals & Clinics

Russell R. Broadus, MD, PhD, FCAP

University of North Carolina Department of Pathology

After a 20 year faculty career at the University of Texas MD Anderson Cancer Center, Russell Broaddus, MD, PhD, moved to the University of North Carolina School of Medicine in Chapel Hill in September, 2019, to be the new Chairman of the Department of Pathology & Laboratory Medicine. He holds the Joe W. and Evelyn Grisham Distinguished Professorship. He is a surgical pathologist with sub-specialty expertise in gynecologic pathology and solid tumor molecular diagnostics. He was the Chair of the College of American Pathologists evidence-based guideline “MMR and MSI Testing in Patients Considered for Checkpoint Inhibitor Therapy.”

Diana M. Cardona, MD, FCAP

Duke University Health System

Dr. Cardona graduated from the University of Miami Miller School of Medicine and completed her Anatomic and Clinical Pathology residency at the University of Florida. She stayed on an additional year as an Adjunct Clinical Post-Doctoral Associate in Gastrointestinal and Hepatobiliary Pathology. In 2009 she started as faculty at Duke University. Her primary clinical responsibilities revolve around GI, liver, transplant and orthopedic surgical pathology services. After having served as the Medical Director for the Surgical Pathology and Immunopathology laboratories for 5 years, Dr. Cardona became Vice Chair and Director of Duke University Health Anatomic Pathology Laboratories in 2019 and Associate Medical Director of Duke Health Clinical Laboratories in 2021. Within her state, Dr. Cardona currently serves as the Vice President of the NC Society of Pathologists. Within the College of American Pathologists (CAP), Dr. Cardona has served as the Chair of the Measure and Performance Assessment Subcommittee, leading the CAP’s Quality Payment Program advocacy and quality payment measure development efforts, and Vice Chair of the CAP’s Economic Affairs Committee. Currently she serves as the Chair of the newly created Quality and Clinical Data Registry Committee and is a member of the Council on Government and Professional Affairs.

John Casler, MD, FACS

Mayo Clinic

John D. Casler, MD, FACS is an Associate Professor, Department of Otolaryngology – Head & Neck Surgery at Mayo Clinic in Jacksonville. He received his BA at Johns Hopkins University, MD at George Washington University and completed his residency training at Walter Reed Army Medical Center. Following his residency in Head & Neck Oncologic Surgery, he focused his clinical and research efforts in improving the treatment of head and neck cancers through innovative surgical approaches. His surgical practice is focused on Head & Neck tumors, particularly thyroid and parathyroid.

Zong-Ming "Eric" Chen, MD, PhD, FCAP

Mayo Clinic

Dr. Chen is a senior associated consultant and associate professor of pathology and laboratory medicine at Mayo Clinic, Rochester, MN. His clinical specialty interest is in pathological diagnosis of GI, pancreas and liver diseases and clinical application of immunohistochemistry in cancer diagnosis and predicative biomarker evaluation. He currently serves as vice chair of informatic operations, leader of predictive and prognostic biomarker utilization group and associate director of GI pathology resident/fellowship training program in the division of anatomic pathology. Dr. Chen is active in research and education. He has published more than 60 peer reviewed articles, 11 book chapters and co-edited two textbooks in diagnostic application of immunohistochemistry and GI pathology, respectively. He also serves as committee member for several national and international organizations including CAP IHC committee, USCAP resident advisory subcommittee, pathology committee of international liver transplant society and board member of international quality network of pathology (IQNPath). He is one of the GI section editors for Archive of Pathology &Laboratory Medicine.

Jerome Y. Cheng, MD

Unversity of Michigan

Dr. Cheng is a Clinical Assistant Professor of Pathology in the Division of Pathology Informatics, in the Department of Pathology at University of Michigan. He is board certified in AP/CP and Clinical Informatics. Research interests include image analysis, natural language processing, data mining, and application of machine learning techniques such as convolutional neural networks and Random Forests to image and non-image based medical datasets.

Won-tak Choi, MD, PhD

University of California San Francisco

Dr. Won-Tak Choi is an Associate Professor in the Department of Pathology at the University of California, San Francisco (UCSF). He received MD and PhD (in Biochemistry) from the University of Illinois at Urbana-Champaign. He completed residency training in Anatomic and Clinical Pathology at the University of Washington and fellowship in Gastrointestinal and Liver Pathology at UCSF. Dr. Choi's research focuses on developing diagnostic and/or prognostic biomarkers for pre-invasive lesions (such as dysplasia and polyps) in the gastrointestinal tract, especially in the setting of inflammatory bowel disease and Barrett’s esophagus. The goal of his work is to use DNA flow cytometry, immunochemistry, and/or molecular testing in conjunction with histologic evaluation to aid in the diagnosis and/or risk stratification of such lesions.

Laura C. Collins, MD, FCAP

Beth Israel Deaconess Medical Center

Dr. Laura C. Collins is the Vice Chair of Anatomic Pathology and Director of Breast Pathology at Beth Israel Deaconess Medical Center in Boston, MA. She is a Professor of Pathology at Harvard Medical School. Dr. Collins graduated from Charing Cross and Westminster Medical School in London and completed her Anatomic and Clinical Pathology Residency Training at the Beth Israel Hospital in Boston followed by a Cytopathology Fellowship at the same institution; now Beth Israel Deaconess Medical Center. In 1998, Dr. Collins joined the faculty at BIDMC as a staff pathologist. During her tenure at BIDMC she has served as the Director of the Residency Training Program in Anatomic and Clinical Pathology as well as the Director of the Selective Pathology Fellowship Training Program. Nationally, she has served the United States and Canadian Academy of Pathology as a member of the Education Committee, Chair of the Residency Advisory Subcommittee and most recently a member of the USCAP Board of Directors. She has also served as the President of the Arthur Purdy Stout Society of Surgical Pathologists. Dr. Collins is an internationally renowned breast pathologist. She has published numerous original articles, review articles and book chapters on breast pathology. She has twice been the guest editor for a monograph on Current Concepts in Breast Pathology in the Surgical Pathology Clinics Series. She co-authored the popular pathology textbook entitled “Biopsy Interpretation of the Breast”, now in its third edition and she was a contributor to several chapters in the WHO Tumors of the Breast, 2012 and 2019. Her research interests are in breast cancer, and in particular the understanding of precursor lesions and early breast neoplasia. In addition to her work in research, Dr. Collins is a committed educator, giving numerous lectures and post-graduate CME courses around the US and the world to support the ongoing education of pathologists and pathologists-in-training in the diagnosis of breast disease.

Julie L. Cruz, MD, FCAP

Versiti Indiana Inc

Allison M. Cushman-Vokoun, MD, PhD, FCAP

University of Nebraska Medical Center

Allison Cushman-Vokoun, MD, PhD, FCAP is board certified in clinical and anatomic pathology, with subspecialty certification in molecular genetic pathology. She completed her combined AP/CP residency at The University of Nebraska Medical Center and MGP Fellowship Training at Vanderbilt University Medical Center. She is the Medical Director of the Molecular Diagnostics Laboratory and the Warren G. Sanger Human Genetics Laboratory at Nebraska Medicine, where she oversees development and sign out of molecular oncology testing. She is also an Associate Professor in the UNMC Department of Pathology and Microbiology with research interests in the molecular pathology and testing of GI-based malignancies. She also serves on the CAP Personalized Health Care Committee, where she leads projects assessing pathology’s role in CAR-T and Gene Editing therapeutic delivery.

Sanja Dacic, MD, PhD

Yale University School of Medicine

Sanja Dacic, MD, PhD, FCAP is a professor of pathology and vice chair and director of anatomic pathology at the Yale School of Medicine. Dr Dacic received her medical degree and a doctor of philosophy degree at the School of Medicine, University of Zagreb, in Zagreb, Croatia. She completed her residency training at the University of Pittsburgh and joined the faculty immediately after her fellowship in surgical pathology. Dr. Dacic is focused on diagnostic pulmonary and molecular pathology and has been involved in many basic and translational research projects in lung cancer and pleural mesotheliomas that have resulted in numerous peer-reviewed scientific articles, book chapters, and reviews. She was a co-author of the original and revised CAP/IASLC/ AMP guidelines for molecular testing in lung cancer. Dr. Dacic is a member of the Editorial Board for the upcoming 5th WHO Classification of Thoracic Tumors.

Cynthia Delgado, MD

University of California, San Francisco

Cynthia Delgado MD, is an Associate Professor of Medicine with the San Francisco Veterans Affairs Healthcare System (SFVAHS) and University of California, San Francisco. She is the Associate Chief of Nephrology for clinical operations and the Director of the Dialysis Program for SFVAHS. She is the Chair of the Diversity and Inclusion Committee for the American Society of Nephrology and served as the co-chair of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. She is a recognized international expert on functional status, frailty, body composition, quality of life and related outcomes among individuals with chronic kidney disease

Amy S. Duffield, MD, PhD, FCAP

Memorial Sloan Kettering Cancer Center

Juanita J. Evans, MD, FCAP

Ascension Providence Hospital Southfield

Juanita Evans, MD, is a pathologist associated with three Ascension Providence Hospitals in the Detroit Metro area where she practices general pathology as well as hematopathology and serves as medical director for one of the facilities. She has served on the CAP New in Practice committee and is currently with the Practice Management committee.

Shaimaa A. Fadl, MBChB, MD

University of Vermont Medical Center

Dr. Shaimaa Fadl is an Assistant Clinical Professor of Radiology at the Virginia Commonwealth University Health System (VCU). She is an active member in both cardiothoracic and emergency radiology sections. Dr. Fadl completed four years of radiology fellowships in 2019 at the University of Washington Medical Center in Seattle Washington. She obtained her American board certification in Radiology in 2019. She joined the VCU as an assistant clinical professor in October 2019.  Dr. Fadl was a recipient of the 2020 RSNA Honored Educator Award.  Dr. Fadl has many publications in both cardiothoracic and emergency radiology literature. She is an active member of different societies including RSNA, NASCI, ASER, and STR.

Valerie A. Fitzhugh, MD, FCAP

Rutgers Robert Wood Johnson Medical School

Dr. Fitzhugh is an associate professor and chair of the Department of Pathology, Immunology and Laboratory Medicine at Rutgers New Jersey Medical School and the Department of Pathology and Laboratory Medicine at Rutgers Robert Wood Johnson Medical School. She is academically productive in her specialty areas of bone and soft tissue pathology and cytopathology, having authored many peer reviewed manuscripts, book chapters, and a book (forthcoming). She is a member of the International Skeletal Society, a society of experts in musculoskeletal medicine which includes pathologists, radiologists, and orthopaedic surgeons. She is the President of the New Jersey Society of Pathologists as well as inaugural Vice-President of the Society of Black Pathologists and the Chair of the College of American Pathologists Diversity, Equity and Inclusion Committee. Dr. Fitzhugh also has interests in the recruitment, retention, and promotion of Black and other underrepresented groups in medicine to pathology as well as racial disparities in treating patients and topics within social justice.

Jennifer Fralick

Stanford Medical Center

Beth E. Frost, DO, FCAP

Office of the Medidcal Examiner

Larissa V. Furtado, MD, FCAP

St. Jude Children's Research Hospital

Billie S. Fyfe-Kirschner, MD, FCAP

Rutgers Robert Wood Johnson Medical School

Chad D. Galderisi, DO, FCAP

ICON Specialty Laboratories

Chiraag N. Gangahar, MD, FCAP

Houston Methodist Hospital

Chiraag N. Gangahar is an AP/CP/Cytopathology-Board Certified Pathologist and from Washington University in St. Louis/Barnes-Jewish Hospital. Prior to residency training, Dr. Gangahar was a Fleet Marine Force Medical Officer with the US Navy and Marine Corps (2011-2016). His dedication to team-building and laboratory quality-improvement led to his being awarded the Paul E. Strandjord Young Investigator Award in 2018 during his residency in St. Louis (2016-2020). During this time he was selected by his peers to be a College of American Pathologists (CAP) Resident Forum Delegate. During his Cytology and Surgical Pathology Fellowships at Houston Methodist (2020-2022), he become a Fellow of the College of American Pathologists (FCAP) and was nominated to the CAP Practice Management Committee, and CAP Digital Content Committee where he currently serves. As a Fellow at Houston Methodist Hospital (2020-2022), he continues to serve patients, performing routine diagnostic services, cytology quality-control, on-site superficial fine needle aspiration, resident teaching, frozen section diagnosis and intra-operative consultation. Dr. Gangahar is a passionate advocate for the role of the Pathologist/Laboratory Physician and a dedicated teacher of residents. He is entering private practice in Dallas, Texas. His hobbies include fitness, music, and the arts.

Jerad M. Gardner, MD, FCAP

Geisinger Medical Center

Jerad M. Gardner, MD, FCAP, is a dermatopathologist and bone/soft tissue pathologist at Geisinger Medical Center in Danville, Pennsylvania. He is a national and international lecturer on dermatopathology, bone and soft tissue sarcoma pathology, and professional use of social media. Dr. Gardner has over 100 peer-reviewed publications as well as multiple book chapters. He is also author of the book Survival Guide to Dermatopathology and co-author of the book Survival Guide to Soft Tissue Pathology. His work has been recognized by multiple awards, including the Resident Advocate Award (2015) and the Outstanding Communicator Award (2018) from the College of American Pathologists and the UAMS Chancellor’s Teaching Award for Teaching Excellence (2018). He was also a top five member of the 2017 “40 Under Forty” by the American Society of Clinical Pathology and was ranked first place on the 2019 Power List of pathology trailblazers issued by The Pathologist magazine. Dr. Gardner is a Deputy Editor-in-Chief of Archives of Pathology & Laboratory Medicine.

Julia Geyer, MD

Weill Cornell Medical College

Dr. Julia Geyer is associate professor of Pathology and Laboratory Medicine at Weill Cornell Medicine. Dr. Geyer is assistant director of hematopathology division and hematopathology fellowship program director. Her interests include bone marrow pathology and myeloid neoplasms.

Giovanna A. Giannico, MD, FCAP

Vanderbilt University Medical Center

Giovanna A. Giannico, MD, FCAP, is an associate professor in Anatomic Pathology and Chief of Genitourinary Pathology at Vanderbilt University Medical Center. Dr. Giannico’s research focuses on neoplastic diseases of the genitourinary tract with emphasis on prostate cancer. She is a member of the CAP Pathology Electronic Reporting Committee (PERT).

James R. Gill, MD, FCAP

Office of the Medical Examiner

Dr. Gill is the Chief Medical Examiner of Connecticut, Chair of the Forensic Pathology Committee of the College of American Pathologists (CAP), and a past President of the National Association of Medical Examiners (NAME). He has faculty medical appointments at Yale, University of Connecticut, and Quinnipiac University. He did his pathology training at Yale and Memorial Sloan-Kettering Cancer Center and his forensic pathology fellowship at the New York City Office of Chief Medical Examiner. Prior to Connecticut, he was the Deputy Chief Medical Examiner for Bronx County in New York City. He has testified over 400 times in criminal and civil matters in State and Federal courts and has published over 100 scientific articles and book chapters on a variety of forensic pathology topics.

Hannah L. Gilmore, MD

Case Western Reserve University

Dr. Gilmore is a board-certified anatomic pathologist specializing in breast pathology at University Hospitals Cleveland Medical Center and Associate Professor of Pathology at Case Western Reserve University in Cleveland, Ohio. Dr. Gilmore has published widely on the pathogenesis of breast tumors and the identification of their diagnostic, predictive and prognostic markers. As the Division Chief of Anatomic Pathology, she made innovative changes to the practice of the discipline with emphasis on subspecialization, multidisciplinary care, molecular diagnostics and digital pathology. She is the College of American Pathologists representative to the National Accreditation Program for Breast Centers where she is Vice Chair of the Standards and Accreditation Committee.

Eric F. Glassy, MD, FCAP

Affiliated Pathologists Medical Group

Dr. Glassy is a community pathologist in Southern California and director of pathology at Providence Little Company of Mary Medical Center, San Pedro. He is a member of Affiliated Pathologists Medical Group, a 40 person independent pathology group covering 15 hospitals and laboratories in California, Portland and Phoenix. Dr. Glassy has won a number of pathology awards, including the Distinguished Service Award and Excellence in Education Award from the College of American Pathologists (CAP). He has chaired hospital and CAP national committees. He served as chairman of the Hematology and Clinical Microscopy, Publications, Digital Pathology, Curriculum, and Information Technology Leadership Committees and the Council on Membership and Professional Development. He is a past Board Member of the CAP Foundation and a graduate of the CAP Engaged Leadership Academy. He is past president of the Digital Pathology Association. He edited, wrote and illustrated several pathology color atlases and developed software programs for pathology reporting, outreach, and practice management. He holds a green belt in Six Sigma. He is a trustee of the American Board of Pathology as well as a board member of the College of American Pathologists. Dr. Glassy received his medical degree from the University of California, San Francisco. He did his pathology residency and hematopathology fellowship at Harbor-UCLA Medical Center.

Dina N. Greene, PhD, DABCC

Kaiser Permanente Washington

Dr. Dina Greene began her scientific career in Gainesville, Florida by obtaining a BS in Microbiology from the University of Florida. From there, she headed to Georgia, obtaining her Ph.D. in Biochemistry at Emory University. Subsequently, ARUP Laboratories convinced her to migrate west to complete the Clinical Chemistry Fellowship Program at the University of Utah. Her career has included directorship positions at Kaiser Permanente (Northwen California and Washington regions) and University of Washington Department of Laboratory Medicine and Pathology. She is currently the Associate Laboratory Director for LetsGetChecked and a Clinical Associate Professor at the University of Washiongton. She has published over 100 peer reviewed articles and book chapters related to clinical chemistry and laboratory medicine and has a particular interest in how sex and gender influence healthcare.

Wayne W. Grody, MD, PhD, FCAP

UCLA Health

Wayne W. Grody, MD, PhD. FCAP is a Professor in the Departments of Pathology & Laboratory Medicine, Pediatrics, and Human Genetics, and the Institute for Society and Genetics, at the UCLA School of Medicine. He is the director of the Molecular Diagnostic Laboratories and the Clinical Genomics Center within the UCLA Medical Center, one of the first such facilities in the country to offer DNA-based tests for diagnosis of a wide variety of genetic, infectious, and neoplastic diseases, as well as bone marrow engraftment, patient specimen identification and paternity testing by DNA fingerprinting, and clinical genomic DNA sequencing for undiagnosed disorders. He is also an attending physician in the Department of Pediatrics, specializing in the care of patients with or at risk for genetic disorders (with a special interest in familial Mediterranean fever, among others), and director of the UCLA Intercampus Medical Genetics Training Program. In addition, he is heavily involved in basic molecular genetics research involving regulation of gene expression of arginase and related enzymes in hereditary arginase deficiency and various cancers, population molecular genetic screening, and construction of artificial human mutation samples. He has been one of the primary developers of quality assurance and ethical guidelines for DNA-based genetic testing for a large number of governmental and professional agencies including the FDA, AMA, CAP, ACMG, ASHG, NCCLS/CLSI, CDC, AMP, VA, ACGME, and the NIH-DOE Human Genome Project (ELSI program). He served as a member of the NIH-DOE Task Force on Genetic Testing, and was the working group chair for development of national guidelines for cystic fibrosis and factor V-Leiden mutation screening. He served for five years as founding chair of the Advisory Committee on Genomic Medicine for the entire VA healthcare system, and is Past President of the American College of Medical Genetics. He was the expert witness for the American Civil Liberties Union in the historic Supreme Court case that invalidated patenting of human genes. Recent awards include the Lifetime Achievement Award from the College of American Pathologists, the Ward Burdick Award for Distinguished Service from the American Society for Clinical Pathology, the Bowes Award Lectureship at Harvard Medical School, the Roscher Endowed Lectureship of the International College of Surgeons, the Leadership Award from the Association for Molecular Pathology, and election as a Fellow of the American Association for the Advancement of Science. As a sidelight, Dr. Grody has been active in the film and television industries for many years, first as film critic for MD Magazine, a national leisure journal for physicians, then as technical advisor and sometime writer for a number of feature films, TV movies, and television series including Life Goes On, Chicago Hope, CSI, Medium, Law and Order, Heroes, Grey’s Anatomy, and both Nutty Professor movies. He did his undergraduate work at Johns Hopkins University, received his M.D. and Ph.D. at Baylor College of Medicine, and completed residency and fellowship training at UCLA. He is double-board-certified by the American Board of Pathology (Anatomic and Clinical Pathology, Molecular Genetic Pathology) and the American Board of Medical Genetics (Clinical Genetics, Molecular Genetics, Biochemical Genetics).

Krisztina Z. Hanley, MD

Emory University Hospital Laboratory

Krisztina Hanley, MD, an Associate Professor of Pathology at the Emory University School of Medicine in Atlanta, GA. She completed her AP/CP residency training at the University of Rochester, NY followed by fellowship training in cytopathology at Emory University and in Gynecologic Pathology and the University of Virginia. She is the director of Gynecologic Pathology and Gynecologic Pathology Fellowship at Emory University Hospital. She is a member of the CAP educational council and CAP CME committee. She also serves her second term on the PEC committee for the American Society of Cytopathology.

Matthew G. Hanna, MD, FCAP

Memorial Sloan Kettering Cancer Center

Matthew G. Hanna, MD, FCAP is the Director of Digital Pathology Informatics and Assistant Attending of Breast pathology and Informatics at Memorial Sloan Kettering Cancer Center, where he completed his Oncologic Pathology fellowship training. Dr. Hanna is boarded in Clinical Informatics, Anatomic and Clinical Pathology. Prior appointments include being a Clinical Instructor of Pathology Informatics at the University of Pittsburgh, where he also completed his Pathology Informatics fellowship. He completed his residency training at The Mount Sinai Hospital in New York. Dr Hanna serves as a member on the CAP Informatics Committee, Artificial Intelligence Committee and chairs the Machine Learning Work Group. He has strong interests in clinical and pathology informatics, and breast pathology.

Donna E. Hansel, MD, PhD, FCAP

Oregon Health & Science University

Dr. Donna Hansel received her undergraduate degree in Biology from The Johns Hopkins University, followed by her MD and PhD degrees at The Johns Hopkins School of Medicine. She was awarded a National Multiple Sclerosis Society fellowship to apply her research to nerve regrowth and pathfinding in the Genetics Department at Erasmus University, The Netherlands. She subsequently undertook a postdoctoral fellowship, followed by residency and a urologic pathology fellowship, at the Johns Hopkins Hospital. She has held faculty positions at the Cleveland Clinic and the University of California San Diego, where she was Division Chief of Anatomic Pathology. She is currently Chair of Pathology and Laboratory Medicine at Oregon Health and Science University in Portland, OR. Dr. Hansel is certified by the American Board of Pathology and is an active member of the diagnostic urologic pathology service. She also oversees a research laboratory focused on identifying high-yield targetable pathways in advanced bladder cancer, wtih a strong emphasis on mTOR signaling and cancer cell invasion. Dr. Hansel has contributed to the 4th and upcoming 5th editions of the WHO Classification of Tumours of the Urinary System and Male Genital Organs, and as also written for the 8th edition AJCC staging manual. Her clinical and translational research results have been presented nationally and internationally and have culminated in over 180 peer-reviewed publications. She frequently lectures on diagnostic criteria and therapeutic challenges in bladder cancer, has authored 6 textbooks, and obtained external peer-reviewed grant funding for her research. She is a member of the Scientific Advisory Board for the Bladder Cancer Advocacy Network and actively supports its efforts to enhance patient understanding of disease and provide community-focused activities. 

Kimberly E. Hanson, MD

ARUP Laboratories, Inc

Dr. Kimberly Hanson is a Professor of Medicine and Pathology at the University of Utah. Administratively, Dr. Hanson serves as the Director of the Immuncompromised Host Infectious Diseases Service and is Section Chief for Clinical Microbiology within ARUP Laboratories. She maintains an active research program that is focused on the development and validation of novel, cost-effective diagnostic tests with a focus on opportunistic infections.

Lara R. Harik, MD, FCAP

Emory University Hospital

Lara R. Harik, MD is Assistant Professor of Pathology at Emory University School of Medicine and Medical Director of the Clinical Laboratory Hospital Service Line at Emory University Hospital, EUOSH and EWWH. Dr Harik completed her residency training in combined Anatomic and Clinical Pathology at Emory University in 2005 followed by 2 years of fellowship training at Memorial Sloan Kettering Cancer Center in New York, in Oncologic Surgical Pathology and Urologic Pathology. Dr. Harik’s experience includes general surgical pathology signout, on faculty at the department of Pathology at Columbia University, as well as subspecialized Genitourinary pathology signout at Emory University. She is heavily involved in educational initiatives and was chair of the Georgia Association of Pathology Education Committee. She serves as the director of the Genitourinary pathology rotation and has received education awards at both Columbia University and Emory University. Dr. Harik’s research focuses on metastatic prostatic adenocarcinoma and bladder carcinoma with variant / divergent histology. She is a member of the College of American Pathologists Cancer Committee, where she works on preparing and updating the widely used GU synoptic worksheets. Dr. Harik believes every day is a great day to learn something new.

Neil S. Harris, MD, FCAP

University of Florida

James H. Harrison, MD, PhD, FCAP

University of Virginia Health System

James Harrison, MD, PhD, is Professor of Pathology and Director of Clinical Laboratory Informatics at the University of Virginia. He is active in pathology information system management, resident training, clinical analytics, and software development. In the College of American Pathologists, he chairs the Informatics Committee, is a member of the Information Technology Leadership Committee, and is liaison to the PIER workgroup on residency training in informatics. He recently led the writing of an overview of artificial intelligence in pathology: Harrison JH, Gilbertson JR, Hanna MG, et al. Introduction to artificial intelligence and machine learning for pathology. Arch Pathol Lab Med. 2021;145(10):1228-1254. doi:10.5858/arpa.2020-0541-cp

Richard L. Haspel, MD, PhD, FCAP

Beth Israel Deaconess Medical Center

Juan C. Hernandez-Prera,MD, FCAP

H Lee Moffitt Cancer Center

Russell A. Higgins, MD, FCAP

UT Health San Antonio

Alina C. Iuga, MD, FCAP

Mount Sinai Medical Center

Dr. Alina Iuga is an associate professor in the Department of Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill and serves as Director of Gastrointestinal Pathology. She enjoys practicing surgical and gastrointestinal pathology since 2012 and has been involved in multiple clinical and translational research projects focused on diseases of the digestive system. Dr. Iuga is board certified in anatomic pathology and has fellowship training in Surgical Oncologic Pathology at MD Anderson Cancer Center, TX and Gastrointestinal Pathology at the Mount Sinai Medical Center, NY.

Dhanpat Jain, MD, FCAP

Yale University School of Medicine

Dr. Dhanpat Jain graduated from Mysore Medical College, Mysore, India and received his M.B.B.S degree in 1986. He subsequently received his M.D. Pathology degree from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India in 1991. He moved to United States in 1995 and completed his Anatomic Pathology residency and Fellowship in Gastrointestinal Pathology at Yale University school of Medicine, and subsequently continued as a faculty at the same institution. Currently he is a Professor of Pathology and Internal Medicine (section of Digestive Diseases) at Yale School of Medicine. Dr. Jain has published about 200 articles, many book chapters, books and reviews, all of which are largely in the field of gastrointestinal and liver pathology. Notably, he is the co-editor of the two-volume textbook on GI pathology along with Dr. Robert Riddell. He has delivered many lectures and participated in many courses at National and International level. He is on the editorial board of several high impact journals in the field of gastrointestinal and liver disorders. His areas of expertise include motility disorders of the gastrointestinal tract, liver fibrosis, metabolic liver diseases, liver neoplasms and gastrointestinal lymphomas for which he gets cases in consultation from across the globe. Dr. Jain is an accomplished teacher and has received many awards. He has continuously been nominated for “Best doctors in America” and “Marquis’s who is who” since many years.

Amy S. Joehlin-Price, MD, MS, FCAP

Cleveland Clinic

Amy S. Joehlin-Price, MD MS, is a staff gynecologic subspecialty pathologist at the Cleveland Clinic, which she joined in 2018. Previously, she received her doctorate of medicine from the Ohio State University College of Medicine in 2012, and subsequently trained in anatomic and clinical pathology at Ohio State and did fellowships in surgical pathology and gynecologic subspecialty pathology at the University of California, San Francisco. Dr. Joehlin-Price’s primary area of interest is endometrial pathology.

Vandita P. Johari, MD, FCAP

Baystate Medical Center

Rebecca L. Johnson, MD, FCAP

American Board of Pathology

Dr. Rebecca Johnson is a Governor with the College of American Pathologists (CAP), elected in 2021. She serves as Vice-Chair of the Council on Education and has previously served on many CAP Committees, Councils, and Work Groups. She is the Chief Executive Officer Emeritus of the American Board of Pathology (ABPath), having been CEO for nine years, a Trustee for 11 years and President in 2009. Dr. Johnson was the Chair of Pathology and Clinical Laboratories and Pathology Residency Program Director at Berkshire Health Systems, MA from 1992-2012.  Dr. Johnson is the Secretary-Treasurer of the American Board of Medical Specialties (ABMS) Board of Directors (BOD), served on their BOD from 2009-18 and on their Executive Committee from 2014-17. She served on the American Council of Graduate Medical Education (ACGME) Pathology Review Committee for six years, including two years as Chair, and nine years as an ex-officio member. She is an active member of many medical organizations, including the AMA, ASCP, CAP, USCAP, the Association of Pathology Chairs (APC), and the Florida Society of Pathologists BOD. Dr. Johnson has received numerous awards including the CAP Distinguished Service Award, President’s Honors, Outstanding Communicator Award, and Certificate of Meritorious Achievement. She received the ASCP Award for Distinguished Service to Pathology and its Mastership designation and the APC Distinguished Teaching Award in Graduate Medical Education. Dr. Johnson received her medical degree from Southern Illinois University School of Medicine and was named its 2010 “Alumna of the Year,”. She completed residency training at Hartford Hospital, CT and Hematology fellowship training at the National Institutes of Health. She is certified by the ABPath in Anatomic and Clinical Pathology, Hematology, and Immunopathology and is participating in the ABPath Continuing Certification program.

Matthew Karafin, MD, FCAP

UNC Blood Research Center

Matthew S. Karafin, MD, FCAP is a clinical associate professor in the department of pathology and laboratory medicine at the University of North Carolina in Chapel Hill. A specialist in blood banking/transfusion medicine, he currently directs the Therapeutic Apheresis Service and the Blood Banking/Transfusion Medicine fellowship program. He is board certified in anatomic pathology, clinical pathology, and transfusion medicine. He is a current member of the CAP Transfusion, Apheresis, and Cellular Therapy Committee.

Bradley S. Karon, MD, PhD, FCAP

Mayo Clinic

Bradley S. Karon, MD, PhD, FCAP, is a professor of laboratory medicine and pathology at Mayo Clinic in Rochester MN. He is chair of the division of clinical core laboratory services at Mayo Clinic Rochester. Dr. Karon’s primary academic interest is in critical and point of care testing, and he has published over 70 peer-reviewed publications that focus primarily on point of care and critical care testing. He is a past chair of the Critical and Point of Care division of AACC and past member of the College of American Pathologists Point of Care Committee.

Julie Katz Karp, MD, FCAP

Thomas Jefferson University Hospitals

Dr. Julie Katz Karp is the Director of Transfusion Medicine and Director of the Transfusion Medicine Fellowship Program at Thomas Jefferson University Hospital in Philadelphia, PA.  She received a Bachelor of Science with distinction from Cornell University and her medical degree from the University of Pennsylvania. She completed residency training in Anatomic and Clinical Pathology at The Johns Hopkins Hospital, where she was also chief resident. She completed a fellowship in Blood Bank/Transfusion Medicine at Thomas Jefferson University Hospital.  Her interests include undergraduate and graduate medical education specifically related to transfusion medicine, as well as blood donor health and recruitment. She served on the CAP Transfusion and Cellular Therapy (TACT) Committee from 2014-2019. Since 2020, she is a member of the CAP Graduate Medical Education Committee. She is board certified in Anatomic and Clinical Pathology and Blood Bank/Transfusion Medicine.

Susan B. Kern, MD, FCAP

Northwest Community Hospital

Susan B. Kern, MD, FCAP, is board certified in anatomic, clinical and cytopathology, was VP and Treasurer of Arlington Ridge Pathology corporation, President of the Medical Staff & voting member of the NW Community Hospital & Healthcare Board, Arlington Heights, IL.; Palatine Township Trustee & Finance Committee Chair as an elected IL. Government official. She is a member of the CAP Practice Management Committee.

Mahmoud A. Khalifa, MD, PhD

University of Minnesota

Professor Mahmoud Khalifa obtained his Medical Degree from Cairo, Egypt where he subsequently received his Master's Degree and PhD in Pathology. He continued his training in pathology at the Universities of Oklahoma, George Washington and Georgetown as well as the Armed Forces Institute of Pathology in Washington, DC. He is certified by the American Board of Pathology and the Royal College of Physicians and Surgeons of Canada. He held several Laboratory Medicine leadership positions in distinguished North American Universities. He currently holds the endowed Donald F. Gleason Professorship and serves as the Medical Director of Anatomic Pathology at the University of Minnesota. Dr. Khalifa’s professional career focuses on Gynecologic Pathology and patient safety. He has authored more than 130 peer-reviewed papers published in these fields. He has received several prestigious teaching awards and has spoken in several national and international meetings.

Mir B. Alikhan, MD

NorthShore University Health System

Lauren King, MD, FCAP

Memphis Pathology Group

Lauren King, MD, FCAP, is currently an Assistant Professor at the University of Tennessee Health Science Center in Memphis. Her areas of interest and expertise are hematopathology and medical education. She is the current chair of the CAP New in Practice Committee.

Christina S. Kong, MD

Stanford Medical Center

Christina Kong, MD is Vice Chair for Clinical Affairs at Stanford Department of Pathology and Medical Director of Pathology & Clinical Laboratory at Stanford Health Care. She did her medical school and residency in Anatomic & Clinical Pathology at UC San Francisco, and fellowship training in Surgical Pathology at Stanford and Cytopathology at UCSF. Since ever-changing shortages became a way of life with the COVID-19 pandemic, she has worked closely with hospital leadership on identifying creative ways to mitigate the impact on pathology and lab services. She also continues to rotate on the cytopathology service where she performs fine needle aspiration biopsies and signs cytology cases with residents and fellows.

Jesse L. Kresak, MD, FCAP

UF Health Shands Hospital

Jesse Lee Kresak, MD, is a Clinical Associate Professor and Vice Chair for Quality and Safety in the Department of Pathology, Immunology, and Laboratory Medicine at the University of Florida in Gainesville and serves as the Director of Anatomic Pathology. She is an active neuropathologist and gastrointestinal pathologist and focuses her efforts on pathology education, quality improvement, and brain tumor research.

Uma Krishnamurti, MD, PhD, FCAP

Emory Universary

Uma Krishnamurti, MD, PhD, FCAP, is currently an Associate Professor in Anatomic Pathology at Yale University School of Medicine. She is board certified in anatomic and clinical pathology and cytopathology. Her areas of interest and expertise are breast and gynecologic pathology. She has served as a member of the CAP Cancer Committee. She is currently Chair of the Research and Current Concepts Committee of the American Society of Cytopathology.

Daniel F.I. Kurtycz, MD, FCAP

University of Wisconsin State Lab of Hygiene

Daniel Kurtycz, MD, is a recently retired Professor in the Department of Pathology and Laboratory Medicine, at the University of Wisconsin-Madison School of Medicine and Public Health. He served as the Medical Director of the Wisconsin State Laboratory of Hygiene (WSLH), the state’s public health laboratory. He received his medical degree from the University of Michigan in 1976 and served his pathology residency at the University of Wisconsin-Madison. In 1985 he took over the directorship of the UW-Madison Cytology Laboratory and the School of Cytotechnology from Dr. Stanley Inhorn at the WSLH. In 1987 he established the University of Wisconsin FNA Service and the UW Cytopathology Fellowship. He also directed the General Pathology Course for the University of Wisconsin School of Medicine (1990-2001) National Service: • Served two terms as Secretary Treasurer of the American Society of Cytopathology • Is Past-President of the American Society of Cytopathology 2020 • Served 7 years as a member of the Cytopathology Test Development Committee of The American Board of Pathology • Served for 9 years on the American Society for Clinical Pathologists Board of Registry for Cytology • Served for 7 Years on the CAP Cytopathology Committee • Is the Current President of the History of Pathology Society (www.hps.wisc.edu) At the WSLH Dr. Kurtycz directed the sections of Cytogenetics, Biochemical Genetics and Newborn Screening. He was part of the surgical pathology team specializing in Breast/GYN at the University of Wisconsin Hospitals and Clinics.

Stephen M. Lagana, MD, FCAP

New York Presbyterian Hospital CUIMC

Stephen Lagana is Associate Professor of Pathology and Cell Biology at Columbia University Medical Center. Stephen practices GI and liver pathology and enjoys working closely with the prestigious Columbia University Celiac Center. Stephen’s research interests are focused on practical issues related to the pathologic manifestations of inflammatory conditions of the intestines and stomach and neoplasms of the liver. He welcomes robust discussion and takes no offense at being challenged regarding any view expressed or omitted.

Moira P. Larsen, MD, MBA, FCAP

Medstar

Moira P. Larsen, MD, MBA is an AP/CP board certified pathologist who has been in practice over 30 years and currently is the Physician Executive Director of MedStar Medical Group Pathology. MedStar Health is an integrated care delivery network in Washington DC and Maryland with 9 acute care hospitals, including an Academic Hospital, a large multispecialty and trauma center and 7 community hospitals of varying sizes and locations in urban and rural areas. In addition to standard laboratory changes in staffing, instrumentation and test menus, she has overseen the consolidation of microbiology laboratories across the network, is nearing completion of the consolidation of histology across 4 community hospitals, and has merged 9 separate pathology practices with distinct employment models into a single practice with nine locations. Through the years, Dr. Larsen has successfully worked through many of the challenges of change management to achieve sustainable improvements in quality, patient safety and financial standing.

Gregory Lauwers, MD, FCAP

H.Lee Moffitt Cancer Center

Dr. Gregory Lauwers is a Senior Member in Anatomic Pathology and Director of the GI Pathology Unit at Moffitt Cancer Center and Professor in the Departments of Oncologic Sciences and Pathology and Cell Biology at the University of South Florida. Dr. Lauwers received his MD from the University of Paris, France. He completed a Surgical Pathology Residency at Lenox Hill Hospital, New York, NY and a Fellowship in Oncologic Pathology at Memorial Sloan-Kettering Cancer Center, where he also served as Chief Fellow. Following his Fellowship, Dr. Lauwers was in the Division of Anatomic Pathology, Department of Pathology at the University of Florida. From 2000 to 2016, Dr. Lauwers was in the Department of Pathology at the Massachusetts General Hospital in Boston. Dr. Lauwers has published over 400 peer-reviewed articles, editorials, reviews, and book chapters, and is coauthor of several textbooks, including the 5th edition of Morson and Dawson's Gastrointestinal Pathology; Advances in Surgical Pathology: Gastric Cancer as well as Diagnostic Pathology: Gastrointestinal. Dr. Lauwers serves on the editorial boards of several journals, he is Deputy Editor-in-Chief of the Archives of Pathology and Laboratory Medicine, and he contributed to the WHO Classifications of Tumours of the Digestive System (2010 & 2019. Dr. Lauwers’ areas of clinical focus include luminal malignancies of the gut (particularly esophageal and gastric adenocarcinoma) and hepatocellular carcinoma.

Julie W. Lemmon, MD

PathGroup

Julie Wilson Lemmon, MD, FCAP is a community pathologist and laboratory medical director at Sumner Regional Medical Center in Gallatin, TN. She is board certified in anatomic and clinical pathology and an avid student of the history of medicine. She has a particular interest in medical museums and their role in early 20th century US medical education. She is currently a candidate for the Master of Arts degree in the History of Medicine from Johns Hopkins University.

Megan S. Lim, MD, PhD, FCAP

University of Pennsylvania Medical Center

Megan S. Lim, MD, PhD, FCAP is the Director of the Division of Hematopathology, Hospital of the University of Pennsylvania, and Professor within the Department of Pathology and Laboratory Medicine, Director of the Hematopathology Fellowship Program, and the Director of the Lymphoma Biology Program at the Abramson Cancer Center. Dr. Lim received an MD from the University of Calgary and a PhD in Molecular Oncology from the University of Calgary and National Cancer Institute Lab of Pathology jointly. Dr. Lim obtained her Hematopathology fellowship training at the National Cancer Institute after which she assumed a faculty position at the University of Toronto (1998-2000), the University of Utah (2000-2006). the University of Michigan (2006-2015) before moving to the University of Pennsylvania in 2015. Dr. Lim is certified by the American Board of Pathology in Anatomic Pathology, with subspecialty certification in Hematopathology and Molecular Genetic Pathology. She has held numerous leadership positions and served on training and education committees for the Association of Molecular Pathology and the United States Academy of Pathology. She is a member of the Board of Directors for the United States Academy of Pathology. She is the Vice-Chair of the Non-Hodgkin Lymphoma Disease Committee of the Children’s Oncology Group and participates in integrated translational research in pediatric lymphoma. Her research interests are focused on elucidating mechanisms involved in lymphoma pathogenesis which are supported by the NIH. She has participated and directed numerous CME activities for AMP, ASCP, CAP, and the USCAP.

Yen-Chun Liu, MD, PhD, FCAP

St. Jude Children's Research Hospital

Sanam Loghavi, MD, FCAP

MD Anderson Cancer Center

Sanam Loghavi is an Associate Professor of Pathology and Laboratory Medicine at the Department of Hematopathology at MD Anderson Cancer Center. She completed her medical school training at Azad University in Tehran, Iran, followed by residency training in anatomic and clinical pathology at Cedars Sinai Medical Center in Los Angeles, California. She pursued further fellowship training in surgical pathology, followed by hematopathology and molecular pathology at MD Anderson Cancer Center. She is Board-certified in hematopathology and molecular pathology and specializes in hematologic malignancies, in particular myeloid neoplasms. Her research interests include molecular risk stratification of hematologic neoplasms and measurable residual disease detection by flow cytometry and next generation sequencing in hematologic malignancies. She is the Medical Director of the ECOG/ACRIN Leukemia Bank at the Central Biorepository and Pathology Facility at MD Anderson. She has authored more than 140 peer-reviewed publications focused on hematologic neoplasms and is a co-investigator on several national and internationally-run clinical trials for hematologic malignancies. She serves on various committees including the HPATH Committee of the College of American Pathologists and the Education and Outreach Committees for International Clinical Cytometry Society.

Giovanni Lujan, MD, FCAP

Ohio State University

Daniel D. Mais, MD, FCAP

University of Texas Health Science Center

Emily Meserve, MD, MPH, FCAP

Spectrum Healthcare Partners

Emily Meserve, MD, MPH, FCAP is a practicing pathologist with Spectrum Healthcare Partners in South Portland, Maine. She completed residency and fellowships at Brigham and Women’s Hospital in Boston, Massachusetts and is board certified in both anatomic and clinical pathology. Dr. Meserve is a member of the College of American Pathologists Immunohistochemistry Committee.

Kamran M. Mirza, MD, PhD, FCAP

Loyola University Medical Center

Kamran M. Mirza, MD, PhD is an Associate Professor of Pathology and Laboratory Medicine, Medical Education, and Applied Health Sciences at Loyola University Chicago Stritch School of Medicine and Parkinson School of Health Sciences and Public Health in Maywood, Illinois. He serves as the Vice-Chair of Education, Program Director of the Hematopathology fellowship, founding Program Director of the M.S. in Medical Laboratory Science, Associate Program Director of the AP/CP residency program, and the Director of medical student pathology education in the Department of Pathology and Laboratory Medicine. An award-winning educator and mentor, Dr. Mirza is the recipient of several dozen local, regional and national teaching awards. Most recently, he was the inaugural recipient of both the regional and national AAMC M. Brownell Anderson Award for New and Emerging Educators, the 2021 CAP’s Pathology Advancement and the 2020 CAP Resident Advocate Award, and the 2022 APC Michele Raible Distinguished Teaching Award. He serves on the CAP Member Engagement Committee, H-PATH committee and was a member of the DEI workforce that helped initiate the CAP DEI committee. Dr. Mirza has been recognized in The Pathologist magazine's Power List 100 consecutively for the past 5 years and he is one of the top 10 most followed Pathologists on Twitter. His research focuses on the molecular basis of hematopoietic malignancies and novel pedagogical tools in pathology education, and ways to improve the pathology pipeline.

Joseph Misdraji, MD, FCAP

Massachusetts General Hospital

Marina Mosunjac, MD, FCAP

Emory Universary

Jonathan L. Myles, MD, FCAP

Cleveland Clinic

Dr. Myles is a national leader in pathology payment policy. He is currently a member of the Board of Governors of the College of American Pathologists (CAP) where he serves as Chair of the Council on Government and Professional Affairs, Vice-Chair of the Council on Scientific Affairs, Board Member of PathPac, and member of the Information Technology Leadership, Compensation, Audit and Finance Committees. Dr. Myles previously served for 11 years as the Pathology Advisor to the AMA-RUC (Relative Value Update Committee) and 7 years as Chair of the Economic Affairs Committee at the CAP. Dr. Myles is a member of the Spokespersons Network and Engaged Leadership Academy of the CAP. Dr. Myles has served on the Board of Directors of the Academy of Medicine of Cleveland and as president of the Ohio Society of Pathologists. Dr. Myles has received the CAP’s Outstanding Service Award as well as the Public Service Award, the College’s highest honor related to public service. Dr. Myles graduated from the Medical College of Ohio in 1983. After completing combined residencies in anatomic and clinical pathology at the Cleveland Clinic in 1987, Dr. Myles joined the faculty of the Medical College of Ohio before being recruited back to the Cleveland Clinic in 1993. Dr. Myles has served in a variety of roles at Cleveland Clinic, including AP education coordinator, director of the autopsy service, director of histology and the surgical pathology desk, and most recently as the Quality Institute Officer for the Robert J. Tomsich Pathology and Laboratory Medicine Institute at Cleveland Clinic. Dr. Myles has practiced both anatomic and clinical pathology and currently serves as a subspecialty pathologist in genitourinary and cardiovascular pathology.

Bita V. Naini, MD, FCAP

UCLA Health

Anupma Nayak, MD

University of Pennsylvania

Ritu Nayar, MD, MBBS, FCAP

Northwestern Memorial Hospital

Ritu Nayar is Professor and Vice Chair of Pathology at Northwestern University’s Feinberg School of Medicine. She is Co-Editor of the Cervical Cytology Bethesda Reporting System for Cervical Cytology; which has served as the model for development and dissemination of many other standardized terminology systems in cytopathology. Dr Nayar is Past President of the American Society of Cytopathology (ASC) and co-author for the ASCCP 2019 Risk Based Consensus Management Guidelines. Currently she is a Trustee and Vice President for the American Board of Pathology and member of the Executive Council of the International Academy of Cytology (IAC). She received the prestigious ASC Papanicolaou Award and IAC Goldblatt Awards in 2018 and the CAP Lifetime Achievement Award in 2019.

Ericka J. Olgaard, DO, FCAP

University of Florida

Ericka Olgaard, DO, MBA, FCAP, is a Clinical Associate Professor and Vice Chair for System Integration in the Department of Pathology, Immunology, and Laboratory Medicine at the University of Florida in Gainesville and serves as the Medical Director of UF Health Pathology Laboratories. She is the Chair of the CAP Accreditation Education Committee and enjoys advancing the fields of quality improvement and laboratory management.

Ajit Paintal, MD, FCAP

NorthShore University

Liron Pantanowitz, MD, MHA, FCAP

University of Michigan

Dr. Liron Pantanowitz is a Professor in the Department of Pathology and the Director of Anatomical Pathology at the University of Michigan in Ann Arbor, MI, USA. He received his medical degree from the University of Witwatersrand in South Africa. He completed his anatomical and clinical pathology residency training at Beth Israel Deaconess Medical Center, Harvard in Boston. He subsequently completed a hematopathology fellowship at Harvard and Cytopathology fellowship at Tufts. He is also board certified by the American Board of Pathology in clinical informatics. Dr. Pantanowitz is an Editor-in-Chief of the Journal of Pathology Informatics. He is a past president and current council member of the Association of Pathology Informatics, president-elect of the American Society of Cytopathology, and a member of the Digital Pathology Association board of directors. He is widely published in the field of pathology informatics and cytopathology. His research interests include digital pathology and artificial intelligence.

Anil V. Parwani, MD, PhD, MBA

Ohio State University Wexner Medical Center

Dr. Anil Parwani is a Professor of Pathology at The Ohio State University. He serves as the Vice Chair and Director of Anatomical Pathology. Dr. Parwani is also the Director of Pathology Informatics and Director of the Digital Pathology. His research is focused on diagnostic and prognostic markers in bladder, prostate and renal cell carcinoma. Dr. Parwani has expertise in the area of surgical pathology, viral vaccines and pathology informatics including biobanking, whole slide imaging, digital imaging, telepathology, image analysis, artificial intelligence and lab automation. Dr. Parwani has authored over 350 peer-reviewed articles in major scientific journals and several books and book chapters. Dr. Parwani is the Editor-in-chief of Diagnostic Pathology and Journal of Pathology Informatics.

Vera Paulson, MD, PhD

University of Washington Medical Center

Vera Paulson, MD, PhD is an assistant professor of Laboratory Medicine and Pathology at the University of Washington Medical Center, Director of Genetics Education, Associate director of the Genetics and Solid Tumors Laboratory, and Associate director of the Genetics Preanalytical Service. Dr. Paulson is board certified in Anatomic, Pediatric, and Molecular Genetic Pathology and her clinical research interests include the design, development, and implementation of genomic methods for utilization in guiding patient care, particularly in the pediatric population. Dr. Paulson is dedicated to teaching, with over 15 years of experience in curriculum development and classroom instruction.

Alexis R. Peedin,MD, FCAP

Thomas Jefferson Univ Hospital

Alexis R. Peedin, MD, FCAP graduated medical school from Rush University in Chicago, and then completed her residency and a blood banking/transfusion medicine fellowship at the University of North Carolina in Chapel Hill, North Carolina. She is board certified in anatomic pathology, clinical pathology, and blood banking/transfusion medicine. Dr. Peedin spent 5 years at Thomas Jefferson University Hospital where she served as assistant director of transfusion medicine, and associate program director for the pathology residency program. She is now working as the Executive Director of Medical Programs for Kaplan, Inc and remains an adjunct faculty member at Jefferson.

Maryam K. Pezhouh, MD, MSc, FCAP

Northwestern Memorial Hospital

Raghavendra Pillappa, MD, MBBS, FCAP

VCU Health Medical Center

Dr. Pillappa is an assistant professor of pathology at the Virginia Commonwealth University, Richmond, Virginia and staff pathologist and the Director of Pulmonary Pathology and Immunohistochemistry at the VCU Health. He is board certified in anatomic and clinical pathology.

Meredith E. Pittman, MD, FCAP

Maimonides Medical Center

Dr. Pittman is the Chief of Gastrointestinal Pathology at Maimonides Medical Center, an independent teaching hospital in Brooklyn, and an assistant professor of pathology at SUNY Downstate Health Sciences University. She serves on the Education Committee for the Hans Popper Hepatopathology Society and on the Journal Watch Committee for the Roger C. Haggitt Gastrointestinal Pathology Society. Dr. Pittman completed her AP/CP residency training at Washington University in St. Louis, followed by a Liver/GI subspecialty fellowship at Johns Hopkins.

Sylvia Plevritis, PhD

Stanford Medical Center

Dr. Sylvia K. Plevritis is Professor and Chair of Biomedical Data Science, Professor of Radiology at Stanford University and Program Director of the Stanford Biomedical Informatics Graduate Training Program. Dr. Plevritis leads a computational biology cancer research program that bridges genomic, imaging and population sciences to decipher properties of cancer progression and treatment response. Dr. Plevritis received her Ph.D. in Electrical Engineering and M.S. in Health Services Research, both from Stanford University, with a focus on cancer imaging physics and predictive modeling of cancer outcomes, respectively. She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and Distinguished Investigator in the Academy of Radiology Research. She serves on the NCI Board of Scientific Advisors, the Program Leadership Committee of the Stanford Cancer Institute and the Leadership Council of the Stanford Bio-X Program. Dr. Plevritis has served on numerous NIH study sections, chaired scientific programs for the several professional societies including the American Association for Cancer Research (AACR) and presented keynote lectures across multiple scales of computational cancer biology and outcomes. Currently, she is the Program Director of the Stanford Center in Cancer Systems Biology (CCSB) and has been a Principal Investigator with the NCI Cancer Intervention Surveillance Network (CISNET) for over fifteen years. She has served as Program Director of the Stanford Cancer Systems Biology Scholars Program (CSBS), and co-Division Chief of Integrative Biomedical Imaging Informatics at Stanford (IBIIS).

Victor G. Prieto, MD, PhD, FCAP

MD Anderson Cancer Center

Victor G Prieto, MD, PhD, FCAP is a pathologist/dermatopathologist with special interest in melanoma. He joined MD Anderson Cancer Center in 1999 as an Assistant Professor, tenure track. Fellowship Director of Dermatopathology between 2001 and 2012 and Fellowship Director of the Surgical Pathology program between 2015 and 2020. He was the section chief of the dermatopathology section between 1999 and 2016 and became the Chair of Anatomical Pathology in 2015. Dr. Prieto has been the Co-Director of the melanoma tissue bank at MDACC for the last 18 years. During this time, he participated in multiple melanoma projects, both within the institution and within the umbrella of the NCI and SPORE groups. These projects have included examination of the pattern of expression of iNOS, retinoid receptors, galectin-3, tyrosin kinases, and related molecules in primary and metastatic melanoma. He has also studied the morphologic predictors of melanoma behavior and analyzed the effectiveness and side effects of the newer targeted and immunotherapies. Dr. Prieto has participated in the drawing of the 8th edition of the AJCC classification of cutaneous melanoma and is also a contributor to the Blue Book of the WHO on cutaneous neoplasms.

Liza Quintana, MD, FCAP

Beth Israel Deaconess Medical Center

Glenn E. Ramsey, MD, FCAP

Northwestern University

Dr. Glenn Ramsey is Professor of Pathology at Feinberg School of Medicine, Northwestern University, and has been the Medical Director of the Blood Bank at Northwestern Memorial Hospital since 1991. His current areas of interest include clinical transfusion practices, disaster preparedness, immunohematology and the application of blood group molecular testing to patient care. He is board certified in anatomic and clinical pathology with subspecialty certification in blood banking and transfusion medicine. He is the chair of the Transfusion, Apheresis and Cell Therapy Committee of the College of American Pathologists, which helps oversee CAP accreditation requirements and proficiency-testing services related to blood banking and cell therapy. He is the CAP representative to the US Department of Health and Human Services Advisory Committee on Blood and Tissue Safety and Availability and to the AABB Interorganizational Disaster Task Force. He has served on several other CAP committees, and is past president of the Illinois Association of Blood Banks. He is the program director of the transfusion medicine fellowship program at McGaw Medical Center of Northwestern University. He received undergraduate and medical degrees from Case Western Reserve University, internal medical internship and pathology residency training at the University of Rochester, and transfusion medicine fellowship training at the University of Pittsburgh and Central Blood Bank, now Vitalant Pittsburgh.

Leslie Randall, MD

VCU Health

Michelle D. Reid, MD, MS, FCAP

Emory University Hospital Laboratory

Dr. Michelle Reid is Professor of Pathology and Director of the Cytopathology at Emory University. She is a board-certified cytopathologist and surgical pathologist with subspecialty interest in pancreatobiliary pathology. She has authored over 150 peer-reviewed journal publications and book chapters on pancreatobiliary tract histopathology and cytopathology. She has given numerous courses, workshops and invited lectures on pancreatobiliary tract pathology at national and international meetings. Her experience as a cytopathologist and surgical pathologist give her unique perspective on the challenges faced by pathologists when interpreting challenging pancreatobiliary tract specimens.

Stephen P. Richmond, MD

Stanford Medical Center

Nicole D. Riddle, MD, FCAP

Tampa General Hospital

Dr. Riddle is a Senior Pathologist for Ruffolo, Hooper, and Associates, providing services at Tampa General Hospital, the Academic Center for the USF Health Morsani College of Medicine, where she is also the Pathology Residency Site Director. There she does General Anatomic Pathology with a focus in Bone & Soft Tissue, Neuropathology, and Gastrointestinal Pathology. She is also Associate Professor, Associate Residency Program Director, and Program Research Liaison for the USF Health Department of Pathology and Cell Biology. She has a specific interest in digital pathology, informatics, high reliable medicine, and creating a culture of quality and patient safety, as well as varied research endeavors. Dr. Riddle has been honored with several awards including the ASCP 2018 “40 under Forty” Top Five, the Pathologist Magazine’s “Power List”, and the 2021 CAP Resident Advocate Award.

Anja C. Roden, MD, FCAP

Mayo Clinic

Dr. Anja C. Roden is Professor of Laboratory Medicine and Pathology and is a board certified Anatomic and Clinical Pathologist with special interest in thoracic and surgical pathology. Dr. Roden did her medical training at the Humboldt University in Berlin and Technical University in Dresden, Germany. After training in general surgery and working in basic immunology science she completed her anatomic and clinical pathology residency, surgical pathology fellowship, and pulmonary Mayo Clinic scholarship at Mayo Clinic Rochester, US. Subsequently, she joined the staff of the Department of Laboratory Medicine and Pathology at Mayo Clinic Rochester, MN, USA contributing to thoracic pathology, surgical pathology, and autopsy. Dr. Roden also serves as the Medical Director of the Immunostains Laboratory and as the Pulmonary Pathology Fellowship Director of Mayo Clinic Rochester. Dr. Roden focuses her research on mediastinal neoplasms, malignant mesotheliomas, biomarkers, interstitial lung diseases, and pulmonary transplant pathology. She published her work in over 150 peer-reviewed manuscript, wrote more than 30 book chapters on mediastinal, pulmonary and mesothelial neoplasms and non-neoplastic lung disease, was involved in the 2021 WHO of thoracic tumors, and was the co-editor of the books “Mediastinal Lesions. Diagnostic Pearls for Interpretation of Small Biopsies and Cytology” and “Pulmonary Pathology. An Atlas and Text”. She also has been an invited speaker on these topics in national and international meetings and congresses. Following her interest she chairs the thymic carcinoma and mediastinal working groups of the International Thymic Malignancy Interest Group, is active in the International Society of the Study of Lung Cancer and Pulmonary Pathology Society and is a member of an International Mesothelioma Panel and an International Virtual Thymoma Panel, and the Immunohistochemistry Committee of the College of American Pathologists. For her work she was the recipient of the President’s Pulmonary Pathology Society Innovation Award in 2017 and the Best Author Award 2020 of Pathology Outlines.

Amyn Rojiani, MD, PhD, CPE, FCAP

Penn State Health Hershey Medical Center

Amyn M. Rojiani MD, PhD is currently Chairman, Department of Pathology, Penn State College of Medicine and Clinical Service Chief for Penn State Health. He recently moved to Hershey, PA after serving as Chair at Medical College of Georgia, Augusta GA for 11 years. A neuropathologist by training, Dr. Rojiani is also a Certified Physician Executive and an active member of the APC, serving as Chair of the Leadership Development and Diversity Committee. He has led multiple workshops and sessions on topics in diversity including microaggressions, racial, gender and intergenerational diversity as well as international medical graduates. His passion has been faculty development and cultivating leadership especially amongst the underrepresented.

Marian Rollins-Raval, MD, MPH, FCAP

TriCore Reference Laboratories

Sinchita Roy-Chowdhuri, MD, PhD, FCAP

UTMD Anderson Cancer Center

Safia N. Salaria, MD, FCAP

Vanderbilt University Medical Center

Eric Salazar, MD, PhD, FCAP

Houston Methodist

Dr. Salazar received his combined MD, PhD degree in 2012 from the Tri-Institutional MD-PhD Program in New York City. Subsequently, he joined the Houston Methodist Department of Pathology and Genomic Medicine as a resident in clinical pathology, as a fellow in transfusion medicine, where he was elected Chief Resident and Chief Fellow. Dr. Salazar is currently the Medical Director of Coagulation Laboratories and Co-Medical Director of Transfusion Medicine. He has an academic appointment as Assistant Professor with the Houston Methodist Hospital Institute for Academic Medicine and Weill Cornell Medical College and Adjunct Assistant Professor with the Texas A&M College of Medicine. He is board-certified in clinical pathology, transfusion medicine, and clinical informatics. Dr. Salazar’s research interests range from improving outcomes in therapeutic apheresis patients to optimal testing of the coagulation system. He is deeply committed to helping stem the negative outcomes associated with the COVID-19 pandemic.

Harold Sanchez, MD, FCAP

Yale

Harry Sanchez, MD FCAP is Assistant Professor of Pathology and Director of the Autopsy Service at the Yale School of Medicine and vice-chair of the Autopsy Committee of the College of American Pathologists.

Ankur R. Sangoi, MD, FCAP

El Camino Hospital

Ankur Sangoi, MD, FCAP, is the medical director of pathology at El Camino Hospital, Mountain View, CA. He completed his anatomic and clinical pathology residency with board certification from Stanford University with subspecialty training in Genitourinary Pathology. He is an adjunct clinical instructor in Stanford’s Department of Pathology, and is active in research with more than 50 publications.

Sadia Sayeed, MD, FCAP

VCU Health

David F. Schaeffer, MD, FRCPC

Vancouver General Hospital

Dr. Schaeffer is an associate professor in the Department of Pathology & Laboratory Medicine at University of British Columbia and the Head of the Division of Anatomic Pathology at Vancouver General Hospital (VGH) where he practices as a gastrointestinal pathologist. Dr. Schaeffer obtained his medical degree from the Johannes Gutenberg University of Mainz, Germany. After a residency program in Anatomical Pathology in Vancouver he completed his gastrointestinal pathology fellowship at Mount Sinai Hospital in Toronto. Dr. Schaeffer is a co-director of Pancreas Centre BC and also heads the Gastrointestinal Biobank (GIBB) at VGH. He has an active research program focusing predominately on translational research in colonic and pancreatic cancer.

Namrata Setia, MD. MBBS

University of Chicago Medical Center

Leslie M. Shaw, PhD

University of Pennsylvania

Leslie M Shaw, PhD, Professor, directs the Biomarker Research Laboratory at the Perelman School of Medicine, University of Pennsylvania, in the Department of Pathology and Laboratory Medicine. He is PI and leader of the ADNI Biomarker Core laboratory and co-leads the Biomarker Core of the UPenn ADRC. He has published more than 300 scientific papers and reviews in the peer-reviewed literature. Amongst the major interests of Dr Shaw are assessment and validation of pre-analytical steps involved in analyses of biofluids and the development and validation of mass spectrometry and immunoassay methods for quantification of CSF AD biomarkers including Aβ42 and related Aβ peptides, t-tau and p-tau181 and new promising biomarkers in CSF and plasma for early disease detection. Dr Shaw is especially interested in studies on the predictive performance of AD biomarkers for AD disease progression and relationships to imaging biomarkers in AD and AD-related disorders.

Nikoletta Sidiropoulos, MD, FCAP

University of Vermont Medical Center

Karim E. Sirgi, MD, MBA, FCAP

Sirgi Consulting

Shane David Basil Smith, MD

UMKC Pathology

Shane D. B. Smith, MD, is a surgical pathology fellow at Atrium Health Wake Forest Baptist in Winston-Salem, North Carolina. He completed his residency training at George Washington University and the University of Missouri-Kansas City. He is board certified in anatomic and clinical pathology with special interests in hidradenitis suppurativa and alopecia.

Brenda Suh-Lailam, PhD, DABCC

Lurie Children's Main Hospital

Dr. Brenda Suh-Lailam is the Director of Clinical Chemistry, Point-of-Care testing, and Quality in the Department of Pathology and Laboratory Medicine at the Ann & Robert H. Lurie Children’s Hospital of Chicago. She is also an Associate Professor of Pathology at the Northwestern University Feinberg School of Medicine in Chicago, IL. Her interests include practices that ensure a high quality of laboratory testing, pediatrics, and point-of-care testing. As an Associate Professor of Pathology, Brenda is directly involved in the training of fellows, residents, medical students, and medical technology students, and has been the recipient of the Outstanding Teacher Award in recognition of stellar teaching contributions to the Northwestern University Feinberg School of Medicine. She is an active member of the American association of Clinical Chemistry where she has served on multiple AACC committees.

Mark S. Synovec, MD, FCAP

Topeka Pathology Group LLC

Laura J. Tafe, MD, FCAP

Dartmouth-Hitchcock Medical Center

Brent T. Tan, MD, PhD, FCAP

Stanford Healthcare

Lynne Uhl, MD, FCAP

Beth Israel Deaconess Medical Center

Lynne Uhl, MD is the Vice Chair, Division of Laboratory and Transfusion Medicine at the Beth Israel Deaconess Medical Center, Boston, MA and an Associate Professor of Pathology at Harvard Medical School. Dr. Uhl received her medical degree from University of Cincinnati College of Medicine, Cincinnati, OH and completed residency training in pathology at Beth Israel Hospital and Harvard Medical School, Boston, MA. Her areas of interest include evidence-based clinical transfusion practice, blood bank operations, and clinical laboratory operations. She is board-certified in anatomic and clinical pathology and has subspecialty certification in blood banking and transfusion medicine.

Paul VanderLaan, MD, PhD, FCAP

Beth Israel Deaconess Medical Center

Paul A. VanderLaan MD, PhD, FCAP is the Director of Cytopathology and the Director of Thoracic Pathology at the Beth Israel Deaconess Medical Center, and an Associate Professor of Pathology at Harvard Medical School. His clinical and research interests focus on cytopathology and pulmonary pathology in the setting of both neoplastic and non-neoplastic lung disease. He was an expert panel member for the CAP thoracic specimen collection and handling guideline, serves as an advisory panel member for the upcoming CAP guideline on lung cancer molecular testing, and is a member of the CAP digital and computational pathology committee.

Laura Wake, MD

Johns Hopkins Hospital

Dr. Laura M. Wake completed her anatomic and clinical pathology (AP/CP) residency at the University of Nebraska Medical Center and received her hematopathology fellowship training at the National Institutes of Health.She joined the Johns Hopkins Department of Pathology in 2017, and is currently an Assistant Professor in the Division of Hematopathology. She is the Hematopathology Fellowship Program Director and is co-director of the department’s Educational Advisory Committee.Dr. Wake's pathology expertise extends to hematology and hematopathology, with a specific focus on hematologic cancers and lymphoid malignancies. 

Hannah Y. Wen, MD, PhD

Memorial Sloan Kettering Cancer Center

Sean R. Williamson, MD, FCAP

Cleveland Clinic

Sean R. Williamson, MD is the Director of Genitourinary Pathology at the Cleveland Clinic and Professor of Pathology in the Cleveland Clinic Lerner College of Medicine. Originally from Pittsburgh, Pennsylvania, he studied medicine at Temple University School of Medicine in Philadelphia, Pennsylvania, followed by residency and genitourinary pathology fellowship training at Indiana University School of Medicine, Indianapolis, Indiana. Prior to joining the Cleveland Clinic, he practiced in the Henry Ford Health System in the Detroit Metro area, where he was selected by the trainees as the Anatomic Pathology Teacher of the Year 4 times. In 2021, he has recently begun a term as Editor-in-Chief of the International Journal of Surgical Pathology, succeeding Dr. Cyril Fisher. He has contributed to more than 100 peer-reviewed journal articles and is co-author with Dr. Sara Wobker of a recently released textbook Atlas of Genitourinary Pathology: A Pattern Based Approach. He is a lead author for multiple sections (urinary bladder, kidney, and mesenchymal tumors) in the upcoming 5th edition of the World Health Organization Classification of tumors of the urinary system and is a coauthor of the upcoming 5th series AFIP text on tumors of the testis and paratesticular structures. He currently serves on the editorial boards of several journals, including Modern Pathology and Histopathology. His research is focused on diagnostic, prognostic, and staging challenges in surgical pathology, with emphasis on recognizing novel tumor histologic features that correlate with underlying molecular events and significance for patient outcome.

Annika L. Windon, MD, FCAP

Vanderbilt University Medical Center

Annika L. Windon, MD, is an Assistant Professor of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center in Nashville, TN with expertise in gastrointestinal, pancreas, and liver pathology. She received her medical degree from Meharry Medical College and completed her residency training at the Hospital of the University of Pennsylvania. She pursued subsequent training at Johns Hopkins Hospital and completed two Advanced Specialty Training Programs in Surgical and Gastrointestinal Pathology. She is board certified in anatomic and clinical pathology and has served on the CAP Cancer Committee as a past junior member.

Sara E. Wobker, MD, MPH, FCAP

UNC Hospitals

Sara E. Wobker, MD, MPH is an Assistant Professor in the Departments of Pathology and Laboratory Medicine and Urology at the University of North Carolina at Chapel Hill. She completed her AP/CP training and cytopathology fellowship at UNC. She then completed a fellowship in Urologic Pathology at Johns Hopkins. She is currently the Director of Genitourinary Pathology and serves as the Associate Director of Surgical Pathology. Her sign-out responsibilities include urologic pathology and cytopathology. Her research focuses on the clinical translational study of genitourinary malignancies, with a specific interest in histologic variants of urothelial carcinoma and their molecular features.

Christina M. Wojewoda, MD, FCAP

University of Vermont Medical Center

Christi Wojewoda, MD, FCAP is the Director of the Clinical Microbiology Laboratory at the University of Vermont Medical Center and an Associate Professor at the University of Vermont Larner College of Medicine. She received her BS in Medical Microbiology & Immunology at the University of Wisconsin, Madison and her MD at the University of Illinois at Chicago. She completed her Anatomic and Clinical Pathology residency at University Hospitals of Cleveland and her Clinical Microbiology fellowship at Cleveland Clinic. Dr. Wojewoda has been heavily involved in the College of American Pathologists since residency and is currently the State Commissioner for Vermont, New Hampshire and Western Massachusetts for the Laboratory Accreditation Program, the Chair for the Microbiology Committee, and member of the Pathologist Pipeline ad hoc Committee.

Sook-Bin Woo, MD, DMD

Harvard School of Dental Medicine

Geoffrey Wool, MD, PhD, FCAP

University of Chicago Medical Center

Geoffrey Wool MD PhD is an associate professor of pathology at the University of Chicago, where he is the medical director of the Coagulation Laboratory and Blood Bank and directs the Transfusion Medicine fellowship. He received his MD and PhD degrees from the University of Chicago. He completed clinical pathology residency and hematopathology fellowship at UCSF and transfusion medicine fellowship at the University of Chicago. Dr. Wool is a member of the CAP Hemostasis and Thrombosis Committee and has published in the areas of apheresis, viscoelastic testing, platelet function testing, point-of-care coagulation testing, antiphospholipid syndrome, acquired autoimmune bleeding disorders, COVID-19 coagulopathy, vaccine-induced immune thrombotic thrombocytopenia (VITT).

Cecilia Yeung, MD, FCAP

Fred Hutchinson Cancer Reaseach Center

Maryam J. Zenali, MD, FCAP

UCONN Health

Dr. Maryam Zenali, MD is a surgical pathologist in Connecticut. She completed her fellowships in General Surgical Pathology and Cancer Biomarker combined with GI and Liver subspecialty pathology in MD Anderson Cancer Center TX. in 2012. She is currently affiliated with University of Connecticut and practices at UCONN Health, Farmington, CT.

Qihui "Jim" Zhai, MD, FCAP

Mayo Clinic

Qihui "Jim" Zhai, MD, FCAP, is a genuine three-shield Mayo physician. He is not only an excellent diagnostician pathologist; he is also a passionate educator and investigator. Dr. Zhai is a professor of laboratory medicine and pathology at Mayo College of Medicine and a consultant pathologist and director of the FISH Laboratory at Mayo Clinic Florida. He did his pathology residency in Mayo Clinic Rochester and an oncologic pathology fellowship at MD Anderson Cancer Center. He is extremely prolific; he authored more than 100 peer-reviewed articles and edited eight major pathology textbooks, covering a broad spectrum of topics in diagnostic and quality management. He serves as section and leading editor in some most cited pathology journals. His research has been focused on translating emerging molecular advances into diagnostic and therapeutic guidance in daily practice by integrating morphology, immunohistochemistry, and liquid biopsy. Dr. Zhai has been a sought-after national and international speaker, with expertise in the areas of head and neck, thyroid, GU, and diagnostic immunohistochemistry. His "making complex things easier” analytic skills with mindful clinical relevance and a sense of humor make his interactive teachings enjoyable; meanwhile, the audience feels updated and leaves the session with confidence. He has generously donated his time, efforts, and expertise to our pathology societies, including CAP, American Board of Pathology, ASCP, USCAP, Florida Society of Pathologists, Houston Society of Clinical Pathologists, and others. His leading efforts make a significant positive impact on our profession and fellow pathologists. He is currently on the CAP Board of Governors.

Xuchen Zhang, MD, PhD, FCAP

Yale University School of Medicine

Phillip Michaels, MD, FCAP

Beth Israel Deaconess Medical Center

Dr. Phillip Michaels is the Medical Director of Molecular Diagnostics and Hematopathologist at Beth Israel Deaconess Medical Center, Boston, MA. He completed AP/CP residency training as well as hematopathology fellowship training at Beth Israel Deaconess Medical Center/Harvard Medical School. He then completed a molecular genetic pathology fellowship at Brigham and Women’s Hospital/Harvard Medical School. His interests include utilization of molecular diagnostics in hematolymphoid neoplasms, copy number alterations in myeloid neoplasms, as well as medical education in molecular diagnostics. He is a member of the CAP Engaged Leadership Academy.

Emily E. Volk, MD, FCAP

Baptist Health Floyd

Dr. Volk, president of the College of American Pathologists since September 2021, has been active on the CAP Board of Governors since 2013 and in the CAP at large for two decades. She has led numerous CAP committees and councils, including the Council on Government and Professional Affairs, and the Ad Hoc Committee for the Pathologists Quality Registry. Additionally, Dr. Volk served on the PathPAC Board of Directors, and the CAP’s House of Delegates representing both Michigan and Texas. She is on faculty at the University of Louisville School of Medicine and serves as the chief medical officer at Baptist Health Floyd. Prior to moving to the Louisville metropolitan area, Dr. Volk worked as the senior vice president of clinical services and faculty pathologist at University Health System in San Antonio, Texas. Dr. Volk received her undergraduate degree and medical degree from the University of Missouri in Kansas City and her MBA from the University of Massachusetts in Amherst. She completed an anatomic and clinical pathology residency from the Cleveland Clinic Foundation and a cytopathology fellowship from the William Beaumont Hospital in Royal Oak, Michigan.

Kalisha A. Hill, MD, MBA, FCAP

Ascension Illinois

Kalisha Hill, MD, MBA, FCAP, FASCP is Regional Chief Medical Officer for Ascension Illinois (Saint Joseph-Joliet and Saint Mary-Kankakee) and Medical Director of Pathology and Laboratory Services for Ascension Saint Mary-Kankakee. She authored the COVID-19 Clinician Testing Guidelines and is a member of the system COVID -19 Task Force. Dr. Hill is a consultant for the Illinois Department of Public Health CLIA Laboratories.Dr. Hill serves as Governor for the College of American Pathologists and is the Immediate Past-President of the Illinois Society of Pathologists. She received the College of American Pathologists’ Distinguished Patient Care Award in 2018 for her active engagement in community health related activities. Dr. Hill is currently the 2022 recipient of The Pearl Foundation’s Trailblazer Award for Youth Empowerment and Mentorship.A local and national media consultant, including CNN, Dr. Hill provides education to viewers on topics ranging from COVID-19 to the autopsy findings of Mr. George Floyd.Dr. Hill is an Emory University alumnus that attended medical school at the University of Illinois at Chicago, followed by residency in Anatomic and Clinical Pathology at Northwestern Memorial Hospital.Dr. Hill is a wife and mother of twin college age girls. She is a member of Alpha Kappa Alpha Sorority, Inc. and Lake Shore (IL) Chapter of The Links, Incorporated.

Thomas M. Wheeler, MD, FCAP

Dr. Wheeler is Director of Surgical Pathology and Cytopathology at Sagis Diagnostics, PLLC. He is also Distinguished Emeritus Professor and immediate past chair of the Department of Pathology & Immunology at Baylor College of Medicine. Dr. Wheeler currently serves as Chair of the Policy Roundtable Subcommittee for the College of American Pathologists and is a past member (2 terms) of the Board of Governors for CAP.

Stephen Black-Shaffer, MD, FCAP

Harvard Medical School

Stephen Black-Schaffer, MD, is Associate Professor of Pathology at Harvard Medical School (HMS) and Associate Chief of Pathology and Pathology Residency Training Program Director at Massachusetts General Hospital (MGH) in Boston, Massachusetts, where he is a practicing surgical and cytopathologist.Steve is a past chair of the national pathology residency program directors’ association (APC/PRODS) and a past member of the Accreditation Council for Graduate Medical Education’s (ACGME) Pathology Review Committee. He currently the chair of the College of American Pathologists’ (CAP) Economic Affairs Committee and Workgroup on Workforce and Education Policy, and an executive committee member of the CAP Council on Governmental and Professional Affairs. He is Medicare Contractor Advisory Committee (CAC) representative for the Massachusetts Society of Pathologists, of which he is a past president. He is chair of Massachusetts General Physicians Organization’s (MGPO) Clinical Performance and Contracting Committee and serves as representative for the MGPO and MGH on the Mass General Brigham (MGB) Accountable Care Organization Board of Managers.

Natalie Banet, MD, FCAP

Women & Infant's Hospital of Rhode Island

Natalie Banet, MD, is a Pathologist at the Cleveland Clinic in Cleveland, Ohio. She is board certified in anatomic and clinical pathology and has fellowship training in Gynecologic and Cytopathology. Dr. Banet has published scholarly works in the areas of Gynecological and Cytopathology and has a special interest in targeted therapies and diagnostics, cervical pathology, and ovarian cancer. She also is involved in educational efforts which aim to increase equity and diversity within her field and is the Director of the International Society of Gynecological Pathologists Journal Club, as well as a member of the ISGyP LiVE Educational working group.

Jennifer Bennett, MD

University of Chicago

Jennifer A. Bennett, MD, is an assistant professor at the University of Chicago specializing in gynecologic pathology. She completed her anatomic pathology residency at Penn State Hershey Medical Center and was the Robert E. Scully Fellow in Gynecologic Pathology at the Massachusetts General Hospital. Her primary area of interest is uterine mesenchymal neoplasms, in particular, integrating their morphologic and molecular features.

Justin A. Bishop, MD, FCAP

UT Southwestern Medical Center

Justin Bishop, MD, FCAP is the Jane B. and Edwin P. Jenevein, M.D. chair in pathology and chief of anatomic pathology at UT Southwestern Medical Center, USA. Dr. Bishop completed his pathology residency at The Johns Hopkins Hospital. Dr. Bishop is an expert in the surgical pathology diagnosis of head and neck diseases. He has published more than 275 journal articles, several book chapters and books, and lectured extensively both nationally and internationally. Dr. Bishop is the lead author of the recent AFIP Fascicle of Salivary Gland Tumors, and editor for the upcoming WHO Classification of Head and Neck Tumors, and the the editor-in-chief of Seminars in Diagnostic Pathology.

Clare H. Bryce, MD, FCAP

New York Presbyterian Hospital CUIMC

Clare Bryce, MD, FCAP is an Associate Professor of Pathology at the Icahn School of Medicine and Director of Autopsy Services at the Mount Sinai Hospital in New York. She completed an Anatomic and Clinical Pathology residency in Ohio, a Forensic Pathology fellowship at Cook County Medical Examiner in Chicago and a Neuropathology Fellowship at Mount Sinai School of Medicine, obtaining board certification in each. She has practiced in forensic pathology for more than 16 years and forensic neuropathology for seven years, having authored several publications in the fields of forensic pathology, general autopsy pathology and neuropathology. Her particular areas of interest and expertise include cardiovascular pathology, neuropathology and infectious disease pathology at autopsy.

Brandon T. Larsen, MD, PhD, FCAP

Mayo Clinic

Brandon T. Larsen, MD, PhD, FCAP, is a consultant and associate professor in the department of laboratory medicine and pathology at Mayo Clinic in Scottsdale, Arizona. Dr. Larsen is board certified in Anatomic Pathology and has expertise in pulmonary, cardiovascular, and bone and soft tissue pathology.

Joseph Rabban, MD, MPH, FCAP

University of California San Francisco

Dr. Rabban received his undergraduate degree at Brown University; his Medical Degree at Harvard Medical School and Master of Public Health at Harvard School of Public Health. He completed Anatomic Pathology residency, General Surgical Pathology Fellowship, and Cytopathology Fellowship at University of California San Francisco. He completed subspecialty fellowship in gynecologic and breast pathology at Massachusetts General Hospital. Dr. Rabban is currently Professor in the Pathology Department at University of California San Francisco where he is the program director of the gynecologic pathology fellowship. In keeping with his interest in education, Dr. Rabban is Co-Chair of the Education Committee of the International Society of Gynecological Pathologists and a member of the Education Committee of the International Gynecological Cancer Society. He is an editor and author of the new 5th edition of the World Health Organization “blue book” Classification System for Tumors of Female Genital Organs. He is a member of the American Board of Pathology’s Test Development and Advisory Committee. He has taught and directed numerous CME courses for USCAP, American Society for Clinical Pathology, College of American Pathologists and the International Academy of Pathology. He has authored numerous peer-reviewed research articles, clinical reviews, and book chapters in diagnostic gynecologic pathology. Dr Rabban also is Associate Editor of the International Journal of Gynecological Pathology. His particular interests are in evidence-based ovarian and endometrial tumor classification, immunohistochemistry, and hereditary tumor syndromes in gynecologic pathology.

David L. Suster, MD

Rutgers New Jersey Medical School

David Suster, MD, received his medical doctorate from the Tulane University School of Medicine, New Orleans, LA, followed by pathology residency training in AP/CP at Beth Israel Deaconess Medical Center, Harvard Medical School, in Boston, MA. This was followed by a Selective Pathology fellowship at Massachusetts General Hospital, Harvard Medical School, Boston, MA where he focused on thoracic and bone and soft tissue pathology. He then completed a second fellowship in Molecular Genetic Pathology at Mount Sinai Hospital, Icahn School of Medicine, New York, NY. He is currently an assistant professor at Rutgers University/New Jersey Medical School and is board certified in anatomical, clinical, and molecular genetic pathology. Dr. Suster has published over 30 peer-reviewed articles as well as 7 book chapters, and a textbook on pulmonary pathology. His work is centered mainly in the field of thoracic and bone and soft tissue pathology. He has also contributed to the literature in areas of skin tumors, thyroid pathology, breast pathology, gynecological pathology and others. He has presented loco-regional as well as international lectures primarily on the topics of thoracic and bone and soft tissue pathology.

Nadejda Tsankova, MD, PhD

New York Presbyterian Hospital CUIMC

Dr. Nadia (Nadejda) Tsankova, MD/PhD, is an Associate Professor in Pathology and Neuroscience, and the Program Director of Neuropathology fellowship, at the Icahn School of Medicine at Mount Sinai, where she has been on Faculty since 2014. She trained as a clinician-scientist at UT Southwestern Medical Center and afterwards completed her residency in Anatomic Pathology and fellowship in Neuropathology at Columbia University. Dr. Tsankova has over 20 years of expertise in the field of molecular neuroscience and over 10 years of clinical practice as a neuropathologist. As a clinical Neuropathologist, Dr. Tsankova worked closely under the mentorship of the late Dr. Mary Fowkes from 2014 to 2020, with notable contributions to the implementation of newer molecular diagnostic tools in neuropathology and the establishment of institution-wide collaborative effort for the molecular characterization of novel populations isolated from fresh human primary tissues. Also an NIH-funded primary investigator, Dr. Tsankova leads a dynamic basic research laboratory studying the molecular drivers of glial development and glioma progression, using primary patient samples and human-based models. Currently, she is a primary investigator on two NIH R01-funded studies, one of them aiming to elucidate the diversity of glial progenitors during late prenatal human development through single nuclei transcriptomic and chromatin accessibility analyses of frozen autopsy material. Her lab is at the forefront of utilizing state-of-the-art technologies to explore the molecular biology in primary patient-derived specimens and has contributed several published studies and protocols to the biomedical community on how to use such tissue for downstream molecular and functional characterization.

Bruce Wenig, MD

H Lee Moffitt Cancer Center

Deyin Xing, MS, BM, MBBS, PhD

Johns Hopkins Medicine

Benjamin C. Calhoun, MD, PhD, FCAP

University of North Carolina

from last year

Xiaoxian (Bill) Li, MD, PhD, FCAP

Emory University Hospital

from last year